SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

29 Aug 2022 Evaluate
The company's total revenue for the quarter ended June 2022 saw a slight change in the total revenue, having registered a total revenue of Rs. 2958.90 millions.The Company has registered profit of Rs. 411.90  millions for the quarter ended June 2022, a growth of 21.54%  over Rs. 338.90 millions millions achieved in the corresponding quarter of last year.The company reported a good operating profit of 621.40 millions compared to 508.70 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202206 202106 % Var
Sales 2958.90 2854.00 3.68 11144.10 10087.30 10.48 11144.10 10087.30 10.48
Other Income 31.00 24.20 28.10 131.90 181.00 -27.13 131.90 181.00 -27.13
PBIDT 621.40 508.70 22.15 2808.70 2641.20 6.34 2808.70 2641.20 6.34
Interest 0.20 1.80 -88.89 4.20 8.00 -47.50 4.20 8.00 -47.50
PBDT 621.20 506.90 22.55 2804.50 2633.20 6.51 2804.50 2633.20 6.51
Depreciation 74.70 71.60 4.33 270.80 300.40 -9.85 270.80 300.40 -9.85
PBT 546.50 435.30 25.55 2533.70 2332.80 8.61 2533.70 2332.80 8.61
TAX 134.60 96.40 39.63 608.50 564.80 7.74 608.50 564.80 7.74
Deferred Tax 11.30 -37.70 -129.97 0.40 -49.00 -100.82 0.40 -49.00 -100.82
PAT 411.90 338.90 21.54 1925.20 1768.00 8.89 1925.20 1768.00 8.89
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 21.00 17.82 17.82 25.20 26.18 -3.74 25.20 26.18 -3.74

Procter&Gamble Healt Share Price

5021.30 29.00 (0.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×